Zynex Stock News

AQR Capital Management LLC lessened its holdings in shares of Zynex, Inc. (NASDAQ:ZYXI) by 12.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,998 shares of the companys stock after selling 1,824 shares during the quarter. AQR Capital Management LLCs holdings in []

Amalgamated Bank acquired a new stake in Zynex, Inc. (NASDAQ:ZYXI) during the second quarter, Holdings Channel.com reports. The institutional investor acquired 10,571 shares of the companys stock, valued at approximately $164,000. Other hedge funds have also recently added to or reduced their stakes in the company. UBS Asset Management Americas Inc. increased its position in []

Zynex, Inc. (ZYXI) CEO Thomas Sandgaard on Q3 2021 Results - Earnings Call Transcript

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 30.77% and -1.79%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

The mean of analysts' price targets for Zynex Inc. (ZYXI) points to an 86.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among anal

ENGLEWOOD, Colo., Oct. 13, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain ma

ENGLEWOOD, Colo., Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain m

Public health officers have been focused on Covid-19 for the last 18 months and all other public health issues have taken a back seat to Covid-19 response efforts. Opioid overdoses have increased duri

Zynex, Inc. (ZYXI) CEO Thomas Sandgaard on Q2 2021 Results - Earnings Call Transcript

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 14.29% and -0.67%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

ENGLEWOOD, Colo., July 21, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pai

Zynex Inc. (ZYXI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the

ENGLEWOOD, Colo., July 15, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain man

ENGLEWOOD, Colo., July 13, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain

ENGLEWOOD, Colo., July 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain m